05
Pharmaceutical products, preparations, and substances for
the prevention and treatment of cancer, infectious diseases,
allergies, mental illnesses, chemotherapy side effects,
radiation side effects, transplantation side effects, and
viral, metabolic, cardiovascular, vascular, pulmonary,
blood, dermatologic, fibrotic, autoimmune, inflammatory,
neurodegenerative, neuromuscular, dietary deficiency,
hereditary, endocrine, eye, ear, and voice related diseases
and disorders; immunotherapies for the prevention and
treatment of cancer, infectious diseases, allergies, mental
illnesses, chemotherapy side effects, radiation side
effects, transplantation side effects, and viral, metabolic,
cardiovascular, vascular, pulmonary, blood, dermatologic,
fibrotic, autoimmune, inflammatory, neurodegenerative,
neuromuscular, dietary deficiency, hereditary, endocrine,
eye, ear, and voice related diseases and disorders (terms
too vague in the opinion of the International Bureau – Rule
13 (2) (b) of the Regulations); chemical platform
technology, namely, small molecule compounds for inducing
the expression of antioxidant, anti-inflammatory, and
cytoprotective proteins in non-malignant tissues, for
activating the immune system, for modulating blood flow in
ischemic tissues, for upregulating proinflammatory mediators
in tumors, and for treating plant diseases (terms too vague
in the opinion of the International Bureau – Rule 13 (2) (b)
of the Regulations)